checkAd

    EQS-Adhoc  113  0 Kommentare SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted

    EQS-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Joint Venture/Capital Increase
    SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted

    11-May-2023 / 19:14 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Redcare Pharmacy N.V.!
    Long
    131,61€
    Basispreis
    0,94
    Ask
    × 14,32
    Hebel
    Short
    147,98€
    Basispreis
    0,95
    Ask
    × 14,25
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss market (the "Transaction").

    The antitrust clearances were conditions precedent for the execution of the Transaction, under which the business activities of shop-apotheke.ch and Mediservice AG will be merged into a joint company.

    Following the approval, the Transaction will now be closed as planned on short notice, expected to be on 16 May 2023. Furthermore, the capital increase to be carried out as part of the Transaction is expected to be concluded by the end of June 2023 at the latest.

     



    End of Inside Information

    11-May-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: SHOP APOTHEKE EUROPE N.V.
    Erik de Rodeweg 11-13
    5975 WD Sevenum
    Netherlands
    Phone: 0800 - 200 800 300
    Fax: 0800 - 90 70 90 20
    E-mail: Investor.Relations@shop-apotheke.com
    Internet: www.shop-apotheke-europe.com
    ISIN: NL0012044747, DE000A19Y072
    WKN: A2AR94, A19Y07
    Indices: SDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1631243

     
    End of Announcement EQS News Service

    1631243  11-May-2023 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1631243&application_name=news&site_id=wallstreet

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    EQS-Adhoc SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted EQS-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Joint Venture/Capital Increase SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted 11-May-2023 / 19:14 CET/CEST Disclosure of an inside information acc. to Article …

    Schreibe Deinen Kommentar

    Disclaimer